TARBP2 and bladder transitional cell carcinoma: To assess TRBP2 levels during the different phases of the cell cycle, we performed flow cytometry analysis of T24 human urothelial bladder-cancer cells (malignancy grade III; p53ΔY126), stained with anti-TRBP antibody and PI.